Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Laetitia Faridoni-Laurens"'
Autor:
Sophie Tourpin, Laetitia Faridoni-Laurens, Muriel Vayssade, Jean-Charles Ahomadegbe, Jean Bénard, A. Valent, Hedi Haddada
Publikováno v:
International Journal of Cancer. 116:860-869
p53-Related genes, p73 and p63, encode 2 classes of proteins, TA-p73/p63 and DeltaN-p73/p63. TA-p73/p63 demonstrate p53-like properties including gene transactivation and cell death promotion, whereas DeltaN-p73/p63 lack these p53-like functions. Alt
Publikováno v:
Biochemical Pharmacology. 63:1609-1617
As the antimitotic agent vincristine (VCR) has been reported to induce a weak p53 response in some studies, we hypothesised that p73 and p63, the recently described p53 homologues, may replace p53 in triggering apoptosis or cell cycle arrest effector
Autor:
Marie‐Luce Le Bihan, Muriel Vayssade, Jean-Charles Ahomadegbe, Daniel Caput, Jacques Bosq, Laetitia Faridoni-Laurens, Mourad Kaghad, Jean Bénard, François Janot
Publikováno v:
Oncogene. 20:5302-5312
P73, a p53-homologue gene, has been studied for its possible role in head and neck squamous epithelium (HNSE) differentiation and carcinogenesis. P73 RNA and protein were analysed in 50 biopsies, including well- and moderately-differentiated carcinom
Autor:
Laetitia Faridoni-Laurens, Samar Alsafadi, Sophie Tourpin, Serge Koscielny, Jean-Charles Ahomadegbe, Michel Barrois, François Janot, Jean Bénard, Jacques Bosq, Stéphane Temam
Publikováno v:
Cell cycle (Georgetown, Tex.). 7(11)
p73, a p53-related gene, encodes two classes of isoforms with opposing functions: (1) a full-length transactivation-competent p73 protein (TAp73) with tumour suppressor activity; and (2) a group of NH2-terminally truncated, transactivation-deficient
Autor:
Anne Couvelard, François Radvanyi, Laetitia Faridoni-Laurens, Philippe Rougier, Mehdi Karoui, Christophe Penna, Elisabeth Brambilla, Emmanuel Mitry, Brigitte Franc, Thierry Clerici, C Tresallet, Claude Degott, Peggy Charbonnier, Catherine Boileau, Ute Zimmermann, Hélène Hofmann-Radvanyi, Jean-Charles Ahomadegbe, Sylvie Gazzeri, Jean Paul Thiery, Bernard Nordlinger
Publikováno v:
Oncogene
Oncogene, Nature Publishing Group, 2001, 20 (36), pp.5059-5061. ⟨10.1038/sj.onc.1204651⟩
Oncogene, 2001, 20 (36), pp.5059-5061. ⟨10.1038/sj.onc.1204651⟩
Oncogene, Nature Publishing Group, 2001, 20 (36), pp.5059-5061. ⟨10.1038/sj.onc.1204651⟩
Oncogene, 2001, 20 (36), pp.5059-5061. ⟨10.1038/sj.onc.1204651⟩
International audience; Germline specific point mutations in the gene encoding fibroblast growth factor receptor 3 (FGFR3) are associated with autosomal dominant human skeletal dysplasia and craniosynostosis syndromes. Mutations identical to the germ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a236f1bfeb0a56296e7b7378a64ee2
https://hal.archives-ouvertes.fr/hal-02345615
https://hal.archives-ouvertes.fr/hal-02345615